Xencor | Fremdkapital



Loan Capital Veränderung Datum
AbbVie USD 64.53B 4.19B 2025-03
Alnylam Pharmaceuticals USD 1.03B 956K 2025-06
Amgen USD 53.76B 253M 2025-06
Arrowhead Research USD 200.33M 8.59M 2025-06
AstraZeneca USD 25.99B 1.9B 2025-06
Biogen USD 6.28B 1.74B 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Cytokinetics USD 713.04M 67.88M 2025-06
GlaxoSmithKline GBP 15.3B 1.17B 2025-06
J&J USD 38.36B 7.7B 2025-03
MacroGenics USD 0 0 2024-12
Merck USD 33.97B 484M 2025-06
Novartis USD 24.06B 2.4B 2025-06
Pfizer USD 57.5B 137M 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Xencor USD 94.74M 7.1M 2025-06


Xencor Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.